The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients
Abstract
In the present study we assessed the frequency and characteristics of the main causes of morbidity and mortality in SLE during a 5-year period and analyzed the prognostic significance for morbidity and mortality of the main immunologic parameters used in clinical practice. We started in 1990 a multicenter study of 1,000 patients from 7 European countries. All had medical histories documented and underwent medical interview and routine general physical examination when entered in the study, and all were followed prospectively by the same physicians during the ensuing 5 years (1990-1995). Four hundred thirteen patients (41.3%) presented 1 or more episodes of arthritis, 264 (26.4%) had malar rash, 222 (22.2%) active nephropathy, 139 (13.9%) fever, 136 (13.6%) neurologic involvement, 132 (13.2%) Raynaud phenomenon, 129 (12.9%) serositis (pleuritis and/or pericarditis), 95 (9.5%) thrombocytopenia, and 72 (7.2%) thrombosis. Two hundred seventy patients (27%) presented infections, 113 (11.3%) hypertension, 75 (7.5%) osteoporosis, and 59 (5.9%) cytopenia due to immunosuppressive agents. Sixteen patients (1.6%) developed malignancies, with the most frequent primary localizations the uterus and the breast. Several immunologic parameters (anti-dsDNA or antiphospholipid antibodies) were found to have a predictive value for the development of SLE manifestations during the period of the study. Forty-five patients (4.5%) died; the most frequent causes of death were divided similarly among active SLE (28.9%), infections (28.9%), and thromboses (26.7%). A survival probability of 95% at 5 years was found. A lower survival probability (92%) was detected in those patients who presented at the beginning of the study with nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
The bimodal mortality pattern of systemic lupus erythematosus
Urowitz, M. B., Bookman, A. A. M., Koehler, B. E., Gordon, D. A., Smythe, H. A., & Ogryzlo, M. A. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90431-9 · Cited by 1,000
CERVERA, R., KHAMASHTA, M. A., FONT, J., SEBASTIANI, G. D., GIL, A., LAVILLA, P., DOMÉNECH, I., AYDINTUG, A. O., JEDRYKA-GÓRAL, A., RAMÓN, E. D., et al. (1993) · Medicine · doi:10.1097/00005792-199303000-00005 · Cited by 979
Self-citationTHE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS
ESTES, D., & CHRISTIAN, C. L. (1971) · Medicine · doi:10.1097/00005792-197103000-00001 · Cited by 936
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Self-citationDetermination of prognosis in chronic disease, illustrated by systemic lupus erythematosus
Merrell, M., & Shulman, L. E. (1955) · Journal of Chronic Diseases · doi:10.1016/0021-9681(55)90018-7 · Cited by 556
Lupus erythematosus in the 1980s: A survey of 570 patients
Pistiner, M., Wallace, D. J., Nessim, S., Metzger, A. L., & Klinenberg, J. R. (1991) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(91)90057-7 · Cited by 403
A multicenter study of outcome in systemic lupus erythematosus.
Ginzler, E. M., Diamond, H. S., Weiner, M., Schlesinger, M., Fries, J. F., Wasner, C., Medsger, T. A., Ziegler, G., Klippel, J. H., Hadler, N. M., et al. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250601 · Cited by 388
Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
Abu‐Shakra, M., Urowitz, M. B., Gladman, D. D., & Gough, J. (1995) · PubMed · Cited by 376
Cited by
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Mejía, J. C., Aydintug, A. O., Chwalinska-Sadowska, H., de Ramón, E., et al. (2003) · Medicine · doi:10.1097/01.md.0000091181.93122.55 · Cited by 1,377
Self-citationNew insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974
Self-citationUnderstanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.007 · Cited by 908
Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases
Shoenfeld, Y., Gerli, R., Doria, A., Matsuura, E., Cerinic, M. M., Ronda, N., Jara, L. J., Abu-Shakra, M., Meroni, P. L., & Sherer, Y. (2005) · Circulation · doi:10.1161/circulationaha.104.507996 · Cited by 555
Metadata
- Authors
- Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Aydintug, A. O., Jedryka-Góral, A., Ramón, E. D., Fernández-Nebro, A., Galeazzi, M., Haga, H.-J., Mathieu, A., Houssiau, F., Ruiz-Irastorza, G., Ingelmo, M., & Hughes, G. R. V.
- Venue
- Medicine
- Published
- 1999-05
- Volume
- 78
- Issue
- 3
- Pages
- 167-175
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2088340307
- Cited by
- 430
- References
- 39
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients. https://app.cochat.ai/papers/10.1097/00005792-199905000-00003
- The paper
- Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Aydintug, A. O., Jedryka-Góral, A., Ramón, E. D., Fernández-Nebro, A., Galeazzi, M., Haga, H.-J., Mathieu, A., Houssiau, F., Ruiz-Irastorza, G., Ingelmo, M., & Hughes, G. R. V. (1999). Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients. Medicine. https://doi.org/10.1097/00005792-199905000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.